Hypertension as part of the metabolic syndrome

Journal of Human Hypertension

Volumn 22, Issue 12, 2008, Pages 871-874

  Cheung, B M Y ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; GLUCOSE; LIPID; RENIN;

ADRENERGIC STIMULATION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EATING HABIT; FATTY LIVER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMOBILIZATION; LIFESTYLE MODIFICATION; MALIGNANT NEOPLASTIC DISEASE; MENTAL STRESS; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP APNEA SYNDROME;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY;

EID: 57049154495     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.63     Document Type: Article

References (33)

1. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 2002; 162(16): 1867-1872.
2. Cheung BMY, Wat NMW, Man YB, Tam S, Cheng CH, Leung GM et al. Relationship between metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study 2. Am J Hypertens 2008; 21(1): 17-22.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
4. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366(9491): 1059-1062.
5. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444(7121): 881-887.
6. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004; 27(10): 2444-2449.
7. Cheung BMY, Ong KL, Man YB, Wong LYF, Lau CP, Lam KSL. Prevalence of the metabolic syndrome in the United State National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. J Clin Hypertens 2006; 8(8): 562-570.
8. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: A UK population-based cross-sectional study. Diabetologia 2005; 48(4): 649-656.
9. Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J et al. A single factor underlies the metabolic syndrome: A confirmatory factor analysis. Diabetes Care 2006; 29(1): 113-122.
10. Ford ES. The metabolic syndrome is rarer than a blue moon? Diabetes Care 2005; 28(7): 1808-1809.
11. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005; 28(7): 1769-1778.
12. Cheung BMY, Wat NMW, Man YB, Tam S, Thomas GN, Leung GM et al. Development of diabetes in Chinese with the metabolic syndrome - a six year prospective study. Diabetes Care 2007; 30(6): 1430-1436.
13. Cheung BMY, Wat NMW, Tam S, Thomas GN, Leung GM, Cheng CH et al. Components of the metabolic syndrome predictive of its development: A six year longitudinal study in Hong Kong Chinese. Clin Endocrinol 2008; 68(5): 730-737.
14. Davy KP, Hall JE. Obesity and hypertension: Two epidemics or one? Am J Physiol Regul Integr Comp Physiol 2004; 286(5): R803-R813.
15. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog Horm Res 2004; 59: 169-205.
16. Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med 2008; 86(6): 729-734.
17. Walker BR. Cortisol - cause and cure for metabolic syndrome? Diabet Med 2006; 23(12): 1281-1288.
18. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20(4): 537-544.
19. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Finnish Diabetes Prevention Study Group: prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
20. Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC et al Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension 2007; 50(4): 609-616.
21. Cheung BMY, Kumana CR. Should decisions on treatment be based on absolute benefit rather than absolute risk? NZ Med J 2001; 114 214-215.
22. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9(3): 211-224.
23. Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: The Strong Heart Study. Am J Kidney Dis 2008; 51(1): 21-28.
24. Abdeen MB, Chowdhury NA, Hayden MR, Ibdah JA. Nonalcoholic steatohepatitis and the cardiometabolic syndrome. J Cardiometab Syndr 2006; 1(1): 36-40.
25. Chan AO, Jim MH, Lam KF, Morris JS, Siu DC, Tong T et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA 2007; 298(12): 1412-1419.
26. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: A review of the current evidence. Am J Clin Nutr 2007; 86(3): s823-s835.
27. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjonneland A et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007; 14(3): 755-767.
28. Isomaa B, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
29. Thomas GN, Schooling CM, McGhee SM, Ho SY, Cheung BM, Wat NM, et al. for the Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. Metabolic syndrome increases all-cause and vascular mortality: The Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol 2007; 66(5): 666-671.
30. Ong KL, Cheung BMY, Man YB, Wong LYF, Lau CP, Lam KSL. Prevalence, awareness, treatment and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49(1): 69-75.
31. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356(23): 2388-2398.
32. Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS. Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey, 1999-2004. Ann Epidemiol 2008; 8(3): 222-229.
33. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): Case-control study. Lancet 2004; 364: 937-952.